Enlivex Therapeutics Ltd.
NASDAQ:ENLV
1.55 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.277 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.16 | 0.188 | 0.2 | 0.214 | 0.212 | 0.209 | 0.221 | 0.192 | 0.176 | 0.188 | 0.15 | 0.157 | 0.122 | 0.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.16 | -0.188 | -0.2 | -0.214 | -0.212 | -0.209 | -0.221 | -0.192 | -0.176 | -0.188 | -0.15 | -0.157 | -0.122 | -0.117 | 2.277 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 1.999 | 2.857 | 4.452 | 4.349 | 5.035 | 5.176 | 5.7 | 4.201 | 4.11 | 4.682 | 5.166 | 2.679 | 2.539 | 2.497 | 2.152 | 1.202 | 1.36 | 1.372 | 1.874 | 1.576 | 0.696 | 1.578 | 1.624 | 1.045 | 0.668 | 0.918 | 0.111 | 0.424 | 0.883 | 1.099 | 1.791 | 3.297 | 1.935 | 1.858 | 1.887 | 1.713 | 2.142 | 1.952 | 2.047 | 1.231 | 0.721 | 0.442 | 0.529 | 0.137 | 0.048 |
| General & Administrative Expenses
| 0.987 | 1.093 | 0.733 | 1.279 | 1.614 | 1.607 | 1.743 | 1.476 | 1.761 | 1.722 | 2.481 | 1.185 | 1.269 | 1.305 | 1.448 | 0.757 | 0.873 | 0.524 | 0.82 | 0.545 | 0.601 | 0.784 | 0.337 | 0.196 | 0.18 | 0.224 | 0.475 | 0.654 | 0.768 | 1.541 | 1.283 | 1.281 | 1.787 | 2.634 | 2.946 | 1.874 | 1.596 | 1.366 | 1.15 | 0.899 | 0.391 | 0.199 | 0.255 | 0.055 | 0.086 |
| Selling & Marketing Expenses
| -0.16 | -0.188 | 1.437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.827 | 0.905 | 1.439 | 1.279 | 1.614 | 1.607 | 1.743 | 1.476 | 1.761 | 1.722 | 2.481 | 1.185 | 1.269 | 1.305 | 1.448 | 0.757 | 0.873 | 0.524 | 0.82 | 0.545 | 0.601 | 0.784 | 0.337 | 0.196 | 0.18 | 0.224 | 0.475 | 0.654 | 0.768 | 1.541 | 1.283 | 1.281 | 1.787 | 2.634 | 2.946 | 1.874 | 1.596 | 1.366 | 1.15 | 0.899 | 0.391 | 0.199 | 0.255 | 0.055 | 0.086 |
| Other Expenses
| 0 | 0 | 0 | -0.335 | -0.143 | -0.435 | 0.402 | -0.056 | -4.042 | -1.821 | 0.167 | 0.44 | 0.7 | 0.602 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.826 | 3.762 | 5.891 | 5.628 | 6.649 | 6.783 | 7.845 | 5.677 | 5.871 | 6.404 | 7.814 | 3.864 | 3.808 | 3.802 | 3.697 | 1.959 | 2.233 | 1.896 | 2.839 | 2.121 | 1.297 | 2.362 | 2.068 | 1.241 | 0.848 | 1.142 | 0.586 | 1.078 | 1.651 | 2.64 | 3.074 | 4.578 | 3.722 | 4.492 | 4.833 | 3.587 | 3.738 | 3.318 | 3.197 | 2.13 | 1.112 | 0.641 | 0.784 | 0.192 | 0.134 |
| Operating Income
| -2.986 | -3.95 | -6.091 | -5.628 | -6.649 | -6.783 | -7.845 | -5.677 | -5.871 | -6.404 | -7.814 | -3.864 | -3.808 | -3.802 | -3.697 | -1.959 | -2.233 | -1.896 | -2.839 | -2.121 | -1.297 | -2.362 | -2.068 | -1.241 | -0.848 | -1.142 | -0.586 | -1.078 | -1.651 | -2.64 | -3.074 | -4.578 | -3.722 | -4.492 | -4.833 | -3.587 | -3.738 | -3.318 | -3.197 | -2.13 | -1.112 | -0.641 | -0.784 | -0.192 | -0.134 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.624 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.11 | -0.19 | -3.004 | -0.335 | -0.143 | -0.435 | 0.656 | -0.056 | -4.042 | -1.821 | 3.286 | 0.44 | 0.7 | 0.602 | -2.167 | -0.166 | -0.808 | 1.102 | -0.028 | -0.27 | -0.164 | -0.303 | 0.483 | 0.139 | 0.317 | 0.117 | 0.013 | -0.004 | 0.021 | 0.008 | 0.011 | 0.008 | 0.014 | 0.027 | 0.02 | 0.039 | 0.055 | 0.021 | 0.045 | 0.019 | -0.002 | -0.004 | 0.007 | -0.003 | -0.001 |
| Income Before Tax
| -3.096 | -4.14 | -9.095 | -5.963 | -6.792 | -7.218 | -7.189 | -5.733 | -9.913 | -8.225 | -4.736 | -3.424 | -3.108 | -3.2 | -5.864 | -2.125 | -3.041 | -0.794 | -2.867 | -2.391 | -1.461 | -2.665 | -1.585 | -1.102 | -0.531 | -1.025 | -0.573 | -1.082 | -1.63 | -2.632 | -3.063 | -4.57 | -3.708 | -4.465 | -4.813 | -3.548 | -3.683 | -3.297 | -3.152 | -2.111 | -1.114 | -0.645 | -0.777 | -0.195 | -0.135 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.575 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.145 | 0.156 | 0.254 | 0.09 | 0.435 | -0.656 | 0.056 | 4.042 | 1.821 | 0.208 | 0 | 0 | 0 | -0.211 | 0.057 | 0.089 | 1.104 | -0.165 | 0.072 | 0.038 | 0.055 | -0.576 | 0.14 | 0.32 | 0.132 | -0.004 | -0.011 | 0.003 | 0.04 | 0.01 | 0.1 | -0.023 | 0.129 | 0.016 | 0.003 | 0.003 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -3.096 | -4.14 | -9.095 | -5.963 | -6.792 | -7.653 | -6.533 | -5.789 | -13.955 | -10.046 | -4.736 | -3.424 | -3.108 | -3.2 | -5.864 | -2.125 | -3.041 | -0.794 | -2.867 | -2.391 | -1.461 | -2.665 | -1.585 | -1.102 | -0.531 | -1.025 | -0.569 | -1.071 | -1.633 | -2.672 | -3.073 | -4.67 | -3.685 | -4.594 | -4.829 | -3.551 | -3.686 | -3.299 | -3.152 | -2.111 | -1.114 | -0.645 | -0.777 | -0.195 | -0.135 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.575 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.16 | -0.22 | -0.49 | -0.32 | -0.37 | -0.41 | -0.35 | -0.31 | -0.76 | -0.55 | -0.26 | -0.19 | -0.17 | -0.19 | -0.44 | -0.16 | -0.23 | -0.07 | -2.01 | -0.23 | -1.16 | -5.51 | -3.28 | -2.51 | -1.21 | -2.34 | -1.36 | -2.56 | -3.97 | -6.52 | -7.5 | -11.4 | -8.99 | -12.7 | -13.57 | -9.98 | -10.36 | -9.27 | -8.86 | -6.5 | -3.1 | -2.34 | -3.64 | -0.91 | -0.72 |
| EPS Diluted
| -0.16 | -0.22 | -0.49 | -0.32 | -0.37 | -0.41 | -0.35 | -0.31 | -0.76 | -0.55 | -0.26 | -0.19 | -0.17 | -0.19 | -0.44 | -0.16 | -0.23 | -0.07 | -2.01 | -0.23 | -1.16 | -5.51 | -3.28 | -2.51 | -1.21 | -2.34 | -1.36 | -2.56 | -3.97 | -6.52 | -7.5 | -11.4 | -8.99 | -12.7 | -13.57 | -9.98 | -10.36 | -9.27 | -8.86 | -6.5 | -3.1 | -2.34 | -3.64 | -0.91 | -0.72 |
| EBITDA
| -2.826 | -3.762 | -5.891 | -5.414 | -6.437 | -6.574 | -7.624 | -5.485 | -5.695 | -6.216 | -7.664 | -3.707 | -3.686 | -3.685 | -3.808 | -1.83 | -2.084 | -0.738 | -2.942 | -2 | -1.208 | -2.263 | -2.605 | -1.074 | -0.506 | -0.977 | -0.586 | -1.078 | -1.592 | -2.635 | -3.074 | -4.572 | -3.715 | -4.486 | -4.826 | -3.583 | -3.735 | -3.315 | -3.195 | -2.128 | -1.111 | -0.64 | -0.779 | -0.192 | -0.134 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |